The choppy market conditions sometime give the impression that growth plays do not exist, but that is far from the case, with Parexel International (NASDAQ: PRXL) providing the evidence.
Parexel International is a leading contract research organization and boasts some of the world's largest drug, biotech and medical device companies among its clients.
Analysts like PRXL's operational breadth: its clinical research services unit offers clinical trial and data management, study design and recruitment, biostatistical analysis, clinical pharmacology, industry training, and publishing services.
Parexel International is a leading contract research organization and boasts some of the world's largest drug, biotech and medical device companies among its clients.
Analysts like PRXL's operational breadth: its clinical research services unit offers clinical trial and data management, study design and recruitment, biostatistical analysis, clinical pharmacology, industry training, and publishing services.
America's 10 Highest-Paid CEOs of 2011 (and How They Earned It)
The Richest Woman in the World: How Gina Rinehart Earns her Billions

